SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Aug 19, 2019
Document Date
Aug 19, 2019
Form Description
Pre-effective amendment to an S-3 filing
Filing Group
Registration Statements
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.